Current Study Opportunities at The CRC
Studies at CRC can change frequently. For the most up to date information of current enrolling studies please fill out the form on the right or call 314-514-8509 ext 12 to see if you qualify for a study. Studies listed were updated on 1-12-22.
Study #1: Research Study for Adults with Asthma comparing an approved combination inhaler to an investigational combination inhaler and to placebo.
Brief description of study
This study requires 5 visits and 4 phone calls over approximately 10 weeks. To qualify you must be between 18-70 years of age and have asthma for at least 6 months. Subjects may be on rescue medication as needed or be stable on their daily maintenance therapy for at least 4 weeks.
Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.
Study #2: COPD Research Study for those using rescue inhaler as needed or daily maintenance therapy.
Brief description of study
This study requires 5 visits over approximately 7 weeks. Subjects must have physician diagnosed COPD and currently treating with rescue inhalers as needed or a stable daily dose of maintenance medication for at least the past month. Subjects will be over 40 years of age and be a current smoker or have a former smoke history of 10 or more pack years.
Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.
Study #3: Research Study of an investigational oral medication taken twice daily for adults with diagnosed Refractory Chronic Cough including Unexplained Chronic Cough
Brief description of study
This research study requires 20 visits over approximately 52 weeks. Subjects must have persistent cough for at least one year and a diagnosis of Chronic Refractory Cough with insufficient improvement after treatment for underlying conditions or for which no underlying conditions have been determined despite adequate investigation with diagnostic tests and trials of therapy. Subjects are required to wear a 24-hour cough monitor multiple times over the 52 weeks.
Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509
Study #4: Investigational Asthma study comparing an approved combination inhaler versus an investigational combination inhaler.
Brief description of study
This study requires 8 visits over approximately 24 weeks. Morning appointments required. Subjects must have asthma for at least 6 months and currently treating with medium to high dose inhaled steroids for at least 8 weeks. Patients must be 12-80 years of age, non-smoker and BMI (Body Mass Index) of less than 40.
Compensation for participation may be provided to those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509 for more details.
Study #5: An investigational research study of an inhaled triple therapy versus Symbicort for people with moderate to severe asthma.
Brief description of study
This investigational research study has 15 visits. Subjects must be currently using medium to high daily dose inhaled maintenance medication. This study does have a BMI (Body Mass Index) restriction of less than 40. Must be 12-80 years of age and non-smoker with little to no previous smoke history.
Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509
Study #6: COPD Research Study comparing investigational inhaled triple therapy to investigational inhaled double therapy.
Brief description of study
This study requires 12 visits over approximately 55 weeks. A chest x-ray is required within 6 months of or at screening. Subjects must be at least 40 years of age with physician diagnosed COPD and be treating with a daily inhaled maintenance therapy with a stable dose for at least 3 months. Subjects must have experienced a COPD flare requiring treatment with oral steroids or antibiotics or have been hospitalized within the past 12 months.
Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509
Study #7: Asthma Research Study for adults 18-75 years of age who have had asthma for at least one year and treat with a medium to high dose maintenance medication for at least 3 months
Brief description of study
This investigational research study is enrolling moderate to severe asthmatics. The study requires 6 visits over approximately 15 weeks. Study medication is an investigational inhaled corticosteroid (ICS) versus an investigational inhaled corticosteroid plus long-acting beta agonist (ICS/LABA). Pulmonary function test will be performed.
Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509
Study #8: COPD Research Study for patients with severe to very severe COPD and suboptimal inspiratory flow rate
Brief description of study
This research study compares a nebulized anticholinergic medication delivered via jetneb (nebulizer) versus a bronchodilator delivered via a dry powder inhaler. The study requires about 6 visits over approximately 15 weeks. Subjects will be at least 40 years of age and be a current smoker or have a former smoke history of 10 or more pack years. Pulmonary functions tests will be performed.
Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509
Study #9: Moderate to Severe Asthma Research Study for those currently using medium to high dose controller medication for at least 3 months and have required an oral steroid for a flare in breathing at least once in the last 12 months.
Brief description of study
This investigational research study is enrolling moderate to severe asthmatics.
To qualify you must be on inhaled maintenance medications and have required oral steroids at least once in the last year, for asthma. The study consists of 17 visits over approximately 7-8 months. Subjects will remain on current asthma controllers. The study medication is an injectable investigational medication and will be given every 2 weeks. Pulmonary function test will be performed.
Compensation for participation may be provided for those who qualify. Please fill out the Volunteer Questionnaire or call 314-514-8509
